Application of PROTACs in target identification and validation

• Principais autores: Yang Liu (Autor), Jing Liang (Autor), Rui Zhu (Autor), Yueying Yang (Autor), Yali Wang (Autor), Wenyi Wei (Autor), Hua Li (Autor), Lixia Chen (Autor)
• Formato: Livro
• Publicado em: Compuscript Ltd, 2024-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Proteolysis targeting chimeras (PROTACs), as a novel therapeutic drug model, has received widespread attention from academia and the pharmaceutical industry. PROTAC technology has led researchers to focus on developing chemical biology tool properties due to the unique operating mechanism and protei...